Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

Neuhaus O, Strasser-Fuchs S, Fazekas F, Kieseier BC, Niederwieser G, Hartung HP, Archelos JJ.

Neurology. 2002 Oct 8;59(7):990-7.

PMID:
12370451
2.

Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes.

Wandinger KP, Stürzebecher CS, Bielekova B, Detore G, Rosenwald A, Staudt LM, McFarland HF, Martin R.

Ann Neurol. 2001 Sep;50(3):349-57.

PMID:
11558791
3.

Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis.

Qu ZX, Pliskin N, Jensen MW, White D, Arnason BG.

Arch Neurol. 2001 Jan;58(1):87-90.

PMID:
11176940
4.

Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.

Kieseier BC, Archelos JJ, Hartung HP.

Arch Neurol. 2004 Jun;61(6):929-32.

PMID:
15210533
5.

Distinct chemokine receptor and cytokine expression profile in secondary progressive MS.

Sørensen TL, Sellebjerg F.

Neurology. 2001 Oct 23;57(8):1371-6.

PMID:
11673573
6.

Dynamics of immune cell trafficking in interferon-beta treated multiple sclerosis patients.

Hartrich L, Weinstock-Guttman B, Hall D, Badgett D, Baier M, Patrick K, Feichter J, Hong J, Ramanathan M.

J Neuroimmunol. 2003 Jun;139(1-2):84-92.

PMID:
12799025
7.

Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.

Ferrarini AM, Sivieri S, Buttarello M, Facchinetti A, Perini P, Gallo P.

Mult Scler. 1998 Jun;4(3):174-7.

PMID:
9762669
8.

RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b.

Iarlori C, Reale M, Lugaresi A, De Luca G, Bonanni L, Di Iorio A, Feliciani C, Conti P, Gambi D.

J Neuroimmunol. 2000 Jul 10;107(1):100-7.

PMID:
10808056
10.

Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma.

Samson KT, Minoguchi K, Tanaka A, Oda N, Yokoe T, Yamamoto Y, Yamamoto M, Ohta S, Adachi M.

Clin Exp Allergy. 2006 Apr;36(4):475-82.

PMID:
16630152
11.
12.

Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.

Hamamcioglu K, Reder AT.

Mult Scler. 2007 May;13(4):459-70. Epub 2007 Feb 9.

PMID:
17463069
13.

Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.

Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.

J Neuroimmunol. 2005 Feb;159(1-2):155-64. Epub 2004 Dec 28.

PMID:
15652415
14.

B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis.

Ramgolam VS, Sha Y, Marcus KL, Choudhary N, Troiani L, Chopra M, Markovic-Plese S.

J Immunol. 2011 Apr 1;186(7):4518-26. doi: 10.4049/jimmunol.1000271. Epub 2011 Mar 2.

15.

Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis.

Khademi M, Wallström E, Andersson M, Piehl F, Di Marco R, Olsson T.

J Neuroimmunol. 2000 Mar 1;103(2):202-10.

PMID:
10696916
16.

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis.

Noronha A, Toscas A, Jensen MA.

J Neuroimmunol. 1993 Jul;46(1-2):145-53.

PMID:
8360326
17.

Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate.

Neuhaus O, Stüve O, Archelos JJ, Hartung HP.

J Neurol Sci. 2005 Jun 15;233(1-2):173-7. Epub 2005 Apr 20. Review.

PMID:
15949504
18.

Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.

Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.

J Neurol Sci. 2004 Jul 15;222(1-2):65-73.

PMID:
15240198
19.

Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis.

Ossege LM, Sindern E, Patzold T, Malin JP.

Int Immunopharmacol. 2001 Jun;1(6):1085-100.

PMID:
11407304
20.

Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.

Krakauer M, Sorensen PS, Khademi M, Olsson T, Sellebjerg F.

Scand J Immunol. 2006 Aug;64(2):155-63.

Items per page

Supplemental Content

Write to the Help Desk